ARCHIVES

News Analysis: Generic Drug Industry’s Efforts to Eliminate Shortages Raises Antitrust Law Questions

This article is from The Cancer Letter archive.

Vol. 38 No. 17 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Colorectal Screening Rates Lower In Safety Net System

September 25, 2009

NSABP Breast Cancer Prevention Trial Reports Final Results On Tamoxifen

November 25, 2005

NIH appoints panel to review conflict of interest rules.

February 27, 2004

New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds

February 28, 2003

Cancer Program Progress Detailed

March 5, 1976

NCI Advisors To Evaluate SPORE Program; Large Grants to Be Weighed Against R01s

December 12, 1997